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Photocontrol of functional peptides is a powerful tool
for spatial and temporal control of cell signaling
events. We show that the genetically encoded light-
sensitive LOV2 domain of Avena Sativa phototropin
1 (AsLOV2) can be used to reversibly photomodulate
the affinity of peptides for their binding partners.
Sequence analysis and molecular modeling were
used to embed two peptides into the Ja helix of the
AsLOV2 domain while maintaining AsLOV2 structure
in the dark but allowing for binding to effector
proteins when the Ja helix unfolds in the light. Caged
versions of the ipaA and SsrA peptides, LOV-ipaA
and LOV-SsrA, bind their targets with 49- and 8-fold
enhanced affinity in the light, respectively. These
switches can be used as general tools for light-
dependent colocalization, which we demonstrate
with photo-activable gene transcription in yeast.
INTRODUCTION
Peptides regulate a variety of biological processes by acting as
competitive inhibitors (Singh et al., 2005), allosteric regulators
(Lockless and Ranganathan, 1999), and localization signals
(Conti et al., 1998). Photocontrol of peptide activity is a powerful
tool for precise spatial and temporal control of cellular function
(Gautier et al., 2010; Nguyen et al., 2004). Typically, photo-
activation of peptides has been achieved by covalently modi-
fying peptides with chemical groups that inhibit function until
they are removed by light (Mo¨glich and Moffat, 2010; Young
and Deiters, 2007). Because such derivatized peptides must
usually be synthesized in vitro, one challenge of this approach
is getting the peptides into living cells or animals. Additionally,
in most cases the photo-induced reaction is not reversible.
Recently, there has been considerable progress in the use of
naturally occurring photo-activable proteins to engineer light
switches that are genetically encoded and reversible (Kennedy
et al., 2010; Levskaya et al., 2009; Wu et al., 2009; Yazawa
et al., 2009). In the majority of cases, the goal has been to regu-
late the activity of folded protein domains. Here, we examine if
the LOV2 domain from Avena sativa phototropin 1 (AsLOV2)Chemistry & Biology 19,can be used to photomodulate the affinity of peptides for binding
partners (Huala et al., 1997).
AsLOV2 is part of the PAS superfamily of domains (Crosson
and Moffat, 2001). It contains a flavin mononucleotide (FMN)
cofactor located in the center of the PAS fold, as well as a large
a-helical region C-terminal to the fold, termed the Ja helix
(Halavaty andMoffat, 2007; Harper et al., 2003). Upon irradiation
with blue light, a covalent adduct is formed between a cysteine
side chain in the PAS fold and a carbon atom of the FMN
(Crosson and Moffat, 2002; Swartz et al., 2001). Spectroscopy
studies indicate that this leads to a large conformational change
in the domain, including the unfolding of the Ja helix (Harper
et al., 2004a; Swartz et al., 2002). When irradiation ceases, rever-
sion of the thiol bond and conformational change back into the
dark state occurs spontaneously within seconds to hours,
depending on the LOV domain ortholog (Zoltowski et al., 2009).
The large conformation change that occurs within the Ja helix
has been previously harnessed to create a photoswitchable
GTPase termed PA-Rac (Wu et al., 2009); a photoswitchable
variant of the Escherichia coli trp repressor that has enhanced
affinity for DNA in the light termed LOV-TAP (Strickland et al.,
2008, 2010); and a photo-activatable DHFR enzyme (Lee et al.,
2008). In these studies, entire protein domains were fused to
the end of the Ja helix in order to sterically occlude binding
with effector molecules or perturb the conformational state
of the attached domain. Upon blue light irradiation, unfolding
of the Ja helix relieves the steric block or conformational strain.
Because peptides aremore flexible than are folded domains, it
may not be sufficient to place them at the end of the Ja helix
to achieve a steric block; tighter caging may be obtained by
embedding their functionality within the Ja helix (Figure 1). A
similar strategy has been successful for caging coiled-coil pep-
tides in the light-sensitive photo-active yellow protein (PYP; Fan
et al., 2011). In the case of AsLOV2, the challenge is identifying
sequences that incorporate the target binding of the peptide
while maintaining the functionality of the Ja helix. One face of
the Ja helix is exposed to solvent, while the other face forms
hydrophobic interactions with a b sheet in the AsLOV2 domain.
Residues on the surface of the helix are expected to be tolerant
to mutation, whereas the buried residues should be more con-
served. Similarly, most peptides have sets of residues that are
required for binding target proteins, whereas other positions
can be varied. These observations indicate that it may be pos-
sible to identify chimeric sequences for the Ja helix that maintain
key interactions with the AsLOV2 domain but incorporate507–517, April 20, 2012 ª2012 Elsevier Ltd All rights reserved 507
Figure 1. General Design Strategy for Caging Peptides Using the
AsLOV2 Domain
Photoswitches are designed as sequence chimeras between the AsLOV2 Ja
helix and the peptide to be caged. Residues that are important to AsLOV2-Ja
interactions (cyan), important to peptide-target interaction (purple), important
to both interactions (red), and residues that are important to neither interaction
(white) are identified and mutated accordingly. Irradiation unfolds the Ja helix,
and the peptide can bind its target.
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sequence comparisons along with molecular modeling to create
AsLOV2 variants that embed the binding properties of the ipaA
(Tran Van Nhieu et al., 1997) and SsrA (Levchenko et al., 2003)
peptides in the Ja helix.
The usefulness of a photoswitch depends on how much the
activity is enhanced by light irradiation (dynamic range) as well
as theabsoluteactivity in thedarkand in the light.Naturally occur-
ring protein switches vary considerably with regard to absolute
activities and dynamic range, indicating that the appropriate
switching power for a particular application is likely to be system
dependent. For instance, the AsLOV2-derived PA-Rac switch
binds to its effector with an affinity of 2 mM in the dark and
200 nM in the light (Wu et al., 2009), which is appropriate for
modulating cellular signaling because a similar change in binding
affinity occurs when Rac1 naturally cycles between the GDP and
GTP bound state (Thompson et al., 1998). Studies with the wild-
type AsLOV2 domain indicate that it should be possible to create
AsLOV2-based switches that show larger changes in activity
upon light activation. Nuclearmagnetic resonance (NMR) studies
have shown that light activation changes the ratio of docked to
undocked Ja helix from 98.4:1.6 in the dark to 9:91 in the lit state
(Yao et al., 2008). This corresponds to a 3.8 kcal mol1 change in
free energy, which if efficiently harnessed could be used to create
switches that have greater than 100-fold changes in binding
affinity for target molecules. In scenarios that involve competitive
binding to the Ja helix, that is, the helix is either docked against
the LOV domain or bound to an effector molecule, it may be
necessary to stabilize the helix docked state in order to take full
advantage of the free energy perturbation that light activation
provides. Strickland et al. (2010) showed that mutations that
stabilize the docked Ja helix could be used to lower the dark state
affinity of LOV-TAP for DNA and improve its dynamic range from
5- to 70-fold. Here, we identify further mutations that stabilize
a docked Ja helix and show that the peptide switches can also
be tuned by varying the location in which the caged sequence
is embedded in the Ja helix and by varying the intrinsic affinity
of the peptide for its target.
As an application of our tunable peptide photoswitches, we
show that the caged ipaA peptide can be used to induce gene508 Chemistry & Biology 19, 507–517, April 20, 2012 ª2012 Elsevierexpression through light-activated heterodimerization in yeast,
demonstrating that the caged peptides can be used as general
tools for colocalizing proteins in living cells.
RESULTS
Identifying Peptides Compatible with AsLOV2 Caging
To identify protein binding peptides well suited for caging with
the AsLOV2 domain, we searched the protein database (PDB)
for peptide sequences similar to portions of the Ja helix. The
similarity score for each position in the alignment was weighted
based on how likely a match or mismatch was to disrupt caging
or peptide binding. For instance, if a position in the alignment
mapped to residues important for both the AsLOV2-Ja helix
interaction and the peptide-protein interaction, then a large
favorable score was given if the amino acids were identical,
and a large unfavorable score was given if the amino acids
were dissimilar. The importance of a residue to the AsLOV2-Ja
helix interaction or the peptide-protein interaction was assigned
based on how buried the residue was; residues that were more
buried were considered more important. There was little reward
or penalty for conserving amino acids on the surface of the Ja
helix. Using a sliding window of six residues, the sequence of
the Ja helix was aligned with over 3,000 peptide sequences
taken from crystal structures of peptides cocrytallized with their
protein binding partners. Peptides from several hundred struc-
tures were identified as candidates for caging with the AsLOV2
domain. It is worth noting that this approach can be expanded
to also consider known protein binding peptides that have not
been crystallized with their binding partners.
We picked out two peptide sequences for experimental
testing and optimization: a vinculin binding peptide from the
invasin protein ipaA (Izard et al., 2006) and the SsrA peptide
from E. coli, which binds the protease delivery protein SspB
(Levchenko et al., 2003). These sequences were chosen for a
variety of reasons. First, at functionally important residues they
align well with the Ja helix (Figures 2A and 2B). Indeed, several
alternative alignments were identified for the SsrA peptide.
Second, they adopt alternative conformations when binding their
targets, ipaA adopts a helix, whereas SsrA binds in an extended
conformation (Figure S1 available online). By testing both pep-
tides, we examine if our approach can be used to cage peptides
regardless of the conformation they adopt when bound to their
target protein. Third, the peptides have different intrinsic affini-
ties for their target proteins. IpaA binds the D1 domain of vinculin
very tightly, Kd < 1 nM, whereas SrrA binds SspB with an affinity
of 30 nM.
Finally, they have complementary advantages for use in
controlling cell biology. The SsrA and SspB sequences are
specific to bacteria, and therefore it is expected that they will
not interact with other proteins and peptides in higher organ-
isms. Fusing proteins of interest to a photo-activable SsrA and
SspB should provide a general approach for light-induced heter-
odimerization, which can be used to localize proteins in the cell
and activate cell-signaling pathways. Vinculin and ipaA-like
peptides are found in mammals, and therefore caged ipaA
should only be useful as a general tool for colocalization in
orthogonal systems, such as yeast. However, caged ipaA may
be useful for probing vinculin biology in mammalian cells.Ltd All rights reserved
Figure 2. Design of LOV-ipaA and LOV-SsrA
Peptide Photoswitches
(A) Sequence alignment of AsLOV2-Ja, ipaA, and
LOV-ipaA. Ja sequence (blue), ipaA sequence
(purple), chimera sequence (cyan), and designed
residues (red) are indicated.
(B) Sequence alignment of AsLOV2-Ja helix, SsrA
peptide, and three LOV-SsrA designs—LOV-
SsrAC, LOV-SsrAN, and LOV-SsrAM. Ja helix
sequence (blue), SsrA sequence (orange), chimera
sequence (cyan), designed positions (black), and
helix-stabilizing mutations (pink) are indicated.
(C) Model of LOV-ipaA with residues colored as in
(A). Residues N538, I539, A542, and A543 K544
(cyan) as well as residues N537, K541, D545, V546
(purple), and I540 (red) are shown as sticks.
(D) Model of LOV-SsrAC with residues colored as
in (B). Residues A528 and E538 (pink) as well as
residues A542 and A543 (cyan) and N544, D545,
E546, N547, and Y548 (orange) are shown as
sticks.
See also Figure S1.
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as talin (Cohen et al., 2006), to the actin cytoskeleton at focal
adhesions (Saunders et al., 2006) and adherens junctions
(Carisey and Ballestrem, 2011), cellular structures important for
determining cell shape and motility. The ipaA peptide is from
the IpaA protein of the Shigella flexneri bacterium and binds to
the talin binding site on vinculin (Izard et al., 2006). It has been
proposed that IpaA binding prevents vinculin from binding talin,
and thus linking integrin signaling to the actin cytoskeleton.
Selectively photo-controlling the binding of ipaA to vinculin
through the LOV-ipaA photoswitch could render it useful as a
dominant negative inhibitor of vinculin in mammalian cells and
an integral tool for studying the role of vinculin dynamics in cell
motility.
Design of LOV-ipaA
In our search of peptides in the protein database, the first ten
residues of the ipaA VBS1 helical peptide were identified as
a closematch to the last ten residues of the AsLOV2 Ja helix (Fig-
ure 2A). Five of the ten positions are identical, and the hydro-
phobic residues on the Ja helix that make critical contacts with
the AsLOV2 domain b sheet at residues 539, 542, and 543 are
conserved in the alignment with ipaA. Additionally, residues in
the ipaA sequence that make extensive contacts with vinculin
are conserved in the alignment (Ile 612, Ala 615, Ala 616, and
Val 619 in ipaA). This analysis suggests that it should be possible
to design a chimeric sequence for the Ja helix that is compatible
with the AsLOV2 structure and will bind vinculin when undocked
from the AsLOV2 structure.
To design the chimeric sequence, the Rosetta molecular
modeling program was used to assess the impact of altering
the AsLOV2-Ja and vinculin-ipaA complex sequences (Das
and Baker, 2008). Side-chain optimization simulations were
used to thread the first ten residues of ipaA onto the last ten resi-Chemistry & Biology 19,dues of the Ja helix. The Rosetta scores of individual residues
were examined to determine if particular residues in the ipaA
sequence packed unfavorably against the AsLOV2 domain
b sheet. Only the mutation of the residue in position 540 from
aspartic acid to tyrosine showed unfavorable scores. To search
for an alternative amino acid to place at this position, Rosetta
was used to perform a sequence optimization simulation in
which position 540 was allowed to adopt alternative identities
and neighboring side chains were free to adopt new side-
chain conformations. One of the best scoring residues in
the 540 position on the Ja helix was isoleucine. A working
model for LOV-ipaA was then created by using the threaded
AsLOV2-Ja design and adding the remaining eleven residues
of ipaA onto the C-terminal end of Ja using the fragment
insertion capability of Rosetta’s domain assembly protocol
(Figure 2C).
Dark- and Lit-State Binding between LOV-ipaA
and Vinculin D1
We developed a fluorescence polarization competition assay to
measure the binding affinity and kinetics of LOV-ipaA to the
vinculin D1 subdomain under dark, as well as blue light, irradia-
tion conditions (Figure 3A). LOV-ipaA was titrated into a mixture
of the vinculin D1 subdomain bound to ipaA peptide labeled
with the dye 5-(and-6)-Carboxytetramethylrhodamine (TAMRA).
As LOV-ipaA bound to vinculin the dye-labeled peptide was
competed off and its fluorescence polarization signal decreased.
Initial experiments showed that the slow intrinsic off-rate of the
ipaA peptide and LOV-ipaA from vinculin made it possible to
monitor both the kinetics and thermodynamics of binding over
a time course of several hours. Experiments with varying
amounts of LOV-ipaA were fit simultaneously for the on rate
and binding affinity of LOV-ipaA to vinculin D1 in Matlab using
a numerical integration protocol.507–517, April 20, 2012 ª2012 Elsevier Ltd All rights reserved 509
Figure 3. Measurement of Rates and Affinities of LOV-ipaA Binding to Vinculin
(A) Schematic of fluorescence polarization competition assay is shown. TAMRA-labeled ipaA (ipaA*) is bound to vinculin D1 subdomain (vinD1). Vinculin
dissociates from the complex with rates k-1 and k1 and binding affinity KD1. LOV-ipaA (LOVipaA) binds vinculin with rates kon and koff and affinity KD2. Fluo-
rescence polarization decreases as the fraction of TAMRA-ipaA bound to vinculin decreases.
(B and C) Fraction of TAMRA-ipaA bound to vinculin over time with varying concentrations of LOV-ipaA titrated in the dark and (C) under blue light.
(D and E) Surface plasmon resonance measurements and first-order binding fit of LOV-ipaA L514K L531E C450A pseudodark and (E) LOV-ipaA L514K L531E
I532E A536E pseudolit mutants.
See also Figure S2.
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irradiation or dark-state conditions yielded different kinetic
curves (Figures 3B and 3C). The binding affinity of LOV-ipaA
WT in the light is 3.5 nM, whereas it is 69 nM in the dark,
a 19-fold change (Table 1). The change in binding affinity
upon light activation is primarily due to changes in the on
rate for binding; in the dark, the rate constant is 1.3 3
103 M1 s1, and in the light it is 1.4 3 104 M1 s1. Similar
changes were observed for LOV-ipaA mutants that abolish
FMN-thiol bond formation (C450A) and lead to a pseudodark
state or mutants that destabilized the Ja helix (I532E A536E),
causing a pseudo-lit-state conformation. These results are
consistent with the proposed mechanism of caging. In the
dark, the Ja helix is primarily docked against the AsLOV2
domain, and the peptide is presented less frequently to the
target binding site, slowing the on rate for binding. In general,
the on rates for binding are slow both in the lit and dark state.
Peptides and proteins often have kon values greater than 1 3
105 M1 s1 (Alsallaq and Zhou, 2008). The slow rates observed
here are consistent with the helix addition mechanism of ipaA
binding to vinculin, wherein the vinculin D1 4-helix bundle is re-
arranged into a 5-helix bundle through the addition of ipaA
(Nhieu and Izard, 2007).510 Chemistry & Biology 19, 507–517, April 20, 2012 ª2012 ElsevierOptimization of LOV-ipaA
We tested two sets of mutations predicted to enhance the
dynamic range of the LOV-ipaA photoswitch. The first set of
mutations was designed by Strickland et al. (2010) to stabilize
the helical structure of Ja. The mutations, G528A and N538E,
increased the dynamic range of the LOV-TAP photoswitch for
its effector from 5- to 70-fold. When used in the LOV-ipaA
system, the mutations did have a large effect on LOV-ipaA
dark-state binding to vinculin D1, decreasing affinity more than
7-fold to 475 nM (Table 1). However, the mutations also weak-
ened lit-state binding affinity over 10-fold to 110 nM. The net
effect of the G528A and N538E mutations in LOV-ipaA then
was a decrease in the photoswitching dynamic range of the
protein. The weakened affinity for vinculin in the lit state is likely
due to charge-charge repulsion between Glu538 in LOV-ipaA
(G528A and N538E) and a glutamate close to the binding site
of ipaA in vinculin.
We designed a second set of mutations to increase the
dynamic range of the switch, L514K L531E, using the interactive
modeling program FoldIt (Cooper et al., 2010). These mutations
replaced two hydrophobic residues, one in the Ja helix, and the
other on the b sheet contacting the Ja helix, with a salt bridge.
The design was meant to stabilize interactions between theLtd All rights reserved
Table 1. Kinetic Rates of LOV-ipaA Binding Vinculin D1
LOV-ipaA
Construct kon (M




1.3 ± 0.3 3 103 8.0 ± 0.7 3 105 64 ± 9.5
WT dark 1.4 ± 0.1 3 103 9.6 ± 0.1 3 105 69 ± 0.5
Lit mimetic
(I532E A536E)
2.9 ± 2.0 3 104 8.5 ± 0.3 3 105 3.0 ± 1.0
WT blue light 1.3 ± 0.3 3 104 4.5 ± 1.2 3 105 3.5 ± 0.5
L514K L531E
dark
4.5 ± 1.5 3 102 1.1 ± 0.4 3 104 245 ± 5.0
L514K L531E
blue light
2.5 ± 0.1 3 103 1.3 ± 0.1 3 105 5.0 ± 0.1
G528A N538E
dark
1.8 ± 0.3 3 102 8.2 ± 0.2 3 105 475 ± 75
G528A N538E
blue light
8.0 ± 2.0 3 102 1.2 ± 0.1 3 104 160 ± 40
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the dark state. Indeed, the binding affinity of LOV-ipaA L514K
L531E to vinculin D1 in the dark state weakened to 245 nM,
whereas the lit-state affinity increased only slightly to 5 nM.
This set of mutations make LOV-ipaA a photoswitch with a
49-fold difference between the lit- and dark-state effector
binding affinities.
To independently validate results from the florescence polari-
zation competition assay, surface plasmon resonance experi-
ments were also conducted. The on rate, off rate, and binding
affinity of vinculin D1 to LOV-ipaA L514K L531E were measured.
LOV-ipaA L514K L531E pseudolit (I532E A536E; Harper et al.,
2004b) and pseudodark (C450A; Salomon et al., 2000) states
were used. Pseudo-dark-state LOV-ipaA L514K L531E (Fig-
ure 3D) was able to bind vinculin D1 with an on rate of 4.5 3
102 M1 s1 and an off rate of 2.9 3 105 s1. A binding affinity
of 64 nM was calculated from the kinetic data. The on rate was
identical to that measured for LOV-ipaA L514K L531E under
dark-state conditions using the fluorescence polarization assay.
The off rate varied slightly, leading to a 4-fold difference in
binding affinity between the two measurements. In part, the
discrepancy might be due to the fact that it is difficult to fit an
off rate that is so slow. Measuring the LOV-ipaA L514K L531E
pseudolit photoswitch binding to vinculin D1, an on rate of
3.83 104M1 s1 and an off rate of 8.73 105 s1 were obtained
(Figure 3E). Fitting indicated that the binding affinity was 2.3 nM.
These values are similar to the kinetic rates measured for the
LOV-ipaA lit mimetic using the fluorescence polarization assay.
There is a 49-fold increase in binding affinity for vinculin when
LOV-ipaA L514K L531E is activated with light but binding in the
dark is still considerable (245 nM). For some applications, it may
be useful to have a switch that has weaker binding affinity in the
dark. To test if we could switch the range of affinities over which
LOV-ipaA functions, we made a mutation to LOV-ipaA that was
predicted to reduce affinity for vinculin but should have negligible
effect on the interactions between the Ja helix and the LOV
domain. This mutant, L623A, weakened the affinity of the LOV-
ipaA lit-state mimetic for the vinculin D1 domain from 3 nM to
2.4 mM, whereas the dark-state mimetic had no detectableChemistry & Biology 19,binding as monitored with isothermal titration calorimetry, sug-
gesting that binding in the dark is weaker than 40 mM (Figure S2).
Design and Optimization of LOV-SsrA
We extended the design strategy used to cage ipaA in order to
create a second photoswitchable peptide, LOV-SsrA. The SsrA
peptide interacts with the protease delivery protein SspB from
E. coli as a linear epitope using the seven residue sequence
AANDENY (Levchenko et al., 2003). Three possible alignments
between SsrA and the Ja helix were identified in our PDB-wide
search, one toward the N-terminal side of the helix (LOV-SsrAN),
one near the C-terminal end (LOV-SsrAC), and one in the middle
of the helix (LOV-SsrAM; Figure 2B). We first tested the
C-terminal alignment LOV-SsrAC.
In LOV-SsrAC, the two alanines from SsrA were aligned with
A542 and A543 from the last helical turn of the Ja helix, and
the final three residues of the Ja helix were replaced with resi-
dues from the SsrA binding sequence (Figure 2D). Except for
the last leucine, all buried positions in the Ja helix are conserved
with this alignment, which only embeds the peptide in a single
helical turn of the Ja helix. In comparison, the ipaA peptide is
embedded within two helical turns in LOV-ipaA. To measure
the affinity of LOV-SsrA for SspB in the dark and light, a fluo-
rescence polarization competition assay was performed with
TAMRA-labeled SsrA peptide (Nikolovska-Coleska et al.,
2004). Unlike ipaA, SsrA binds rapidly to SspB and only equilib-
rium populations could be measured. The initial LOV-SsrA
design showed a 2-fold change in affinity of 31 nM to 57 nM
when activated with light (Table S1). As lit-state binding was
near-native in affinity for SspB, approaches to stabilize the Ja
helix and therefore decrease dark-state affinity were explored.
We tested mutations previously shown to stabilize the Ja helix,
G528A and N538E, as well as extensions to the C terminus
of LOV-SsrAC. G528A and N538E had the desired effect and
lowered dark-state affinity to 570 nM with a 5-fold change
upon light activation. Extensions of varying lengths were
designed with Rosetta (Kleiger et al., 2009) with the goal of
binding the surface of the AsLOV2 domain, thereby constraining
SsrA to a single, nonbinding conformation. The target surface on
AsLOV2 was a hydrophobic patch immediately adjacent to the C
terminus of the Ja helix. Two extensions were experimentally
tested, the addition of a single phenylalanine and the addition
of the sequence GYGNL. The longer extension had no detect-
able effect, whereas the single phenylalanine increased the
dynamic range of the switch to 8-fold (Figure 4A).
The LOV-SsrAN designs incorporating the N-terminal align-
ment of SsrA had similar dynamic ranges to their corresponding
C-terminal alignments. However, all had drastically reduced
affinity for SspB in both the lit and dark state (>10 mM). The initial
N-terminally aligned designs showed an approximate 2-fold
increase in affinity after exposure to blue light. The addition of
the G528A and N538E mutations slightly weakened the lit-state
affinity for SspB to 12.6 mM and the dark-state affinity to 49 mM
(Figure 4B). Because of constraints imposed by the AsLOV2
domain, the SspB binding sequence used in LOV-SsrAN was
AANDEAY instead of AANDENY as used in LOV-SsrAC. To
determine if the sequence change was responsible for the lower
dark- and lit-state affinities for SspB, a peptide with the same
sequence as LOV-SsrAN was synthesized and binding to SspB507–517, April 20, 2012 ª2012 Elsevier Ltd All rights reserved 511
Figure 4. Competitve Binding of LOV-SsrA to SspB in Blue Light and
in Darkness
(A and B) Competitive binding assay of LOV-SsrAC (A) or LOV-SsrAN (B) to an
equilibrium solution of SspB and 5(6)TAMRA-SsrA. 5(6)TAMRA-SsrA becomes
unbound as LOV-SsrA competes for SspB binding. Binding to SspB was
measured immediately after illumination with blue light (open circles) and after
return to dark state (closed circles).
(C) Reversible binding of LOV-SsrAC to SspB. A single titration point from
the fluorescence polarization competition assay was repeatedly irradiated
with blue light (blue bar = 60 s) and reversion to dark-state equilibrium was
monitored by polarization.
See also Figure S3 and Table S1.
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Designing Phototswitchable Peptideswas measured. Binding was tight, 38 nM, suggesting that the
reduced affinity for SspB was not because of changes to
the binding sequence but rather because of the location within
the Ja helix that the peptide was embedded. Results with
LOV-SsrAM were more ambiguous, as the sequence embedded
in the Ja helix, AANDINY, showed reduced affinity for SspB as a512 Chemistry & Biology 19, 507–517, April 20, 2012 ª2012 Elsevierpeptide (1.9 mM). However, lit- (40 mM) and dark-state (156 mM)
state affinities were still significantly lower than that the isolated
peptide, suggesting again that embedding sequences deeper in
the Ja helix lowers accessibility to the peptide in both dark and
light states (Figure S3).
The reversibility of LOV-SsrA switches was tested by moni-
toring their ability to compete with a TAMRA-labeled SsraA
peptide for binding to SspB over multiple rounds of irradiation
followed by incubation in the dark (Figure 4C). Asmonitored indi-
rectly from following the fluorescence polarization signal from
the SsraA peptide, the fraction of LOV-SsrAmolecules switching
from a bound to unbound state remained unchanged over
multiple rounds of illumination, indicating that the switches are
reversible. To check that the observed results were not an arti-
fact due to interaction between the blue light and the TAMRA
dye, similar reversion experiments were performed with only
SspB and labeled peptide. No polarization changes were
observed after incubation with blue light. The reversibility exper-
iments also showed that dark-state equilibrium was reached
within 15 s, quicker than what has been observed previously
for the AsLOV2 domain. Half-times between 27 and 50 s have
been reported for the LOV2 domain from Avena sativa (Salomon
et al., 2000; Swartz et al., 2001). Using absorption spectroscopy,
we determined the half-life of LOV-SsrAC’s photocycle to be
2.7 ± 0.4 s, with a similar relaxation time in the presence of satu-
rating concentrations of SspB(2.3 ± 0.1 s; Figure S3). At this point
it is not clear why LOV-SsrAC has an unusually fast rate of rever-
sion to the dark state, but this could be advantageous in applica-
tions in which quick switching from the bound to unbound state
is critical.
LOV-ipaA Binding to Full-Length Vinculin: Actin
Cosedimentation Assays
Having established that the AsLOV2 domain could be used to
cage peptides, we tested if LOV-ipaA could be used to perturb
vinculin in a biologically relevant manner. Actin cosedimentation
assays were performed to measure the apparent binding affinity
of LOV-ipaA to full-length vinculin. Vinculin naturally forms an
autoinhibited conformation stabilized by interactions between
the head (including the D1 domain) and tail domains. Binding
of the ipaA peptide to the head domain competes with the auto-
inhibited state and releases the tail domain to bind with polymer-
ized F-actin (Izard et al., 2006). Actin cosedimentation assays
were performed to measure the apparent binding affinity of
LOV-ipaA in the dark and lit state to full-length vinculin. In the
assay, polymerized actin, vinculin, and LOV-ipaA (lit- or dark-
statemutants) were incubated together (Figure 5A). Only vinculin
that bound to LOV-ipaA should be able to interact and bind to
F-actin. The resulting mix of bound and unbound vinculin was
centrifuged at high speeds, resulting in fractionation of F-actin
polymers out of solution, along with the vinculin-LOV-ipaA com-
plexes that had bound to them. A sodium dodecyl sulfate poly-
acrylamide gel electrophoresis (SDS-PAGE) gel was used to
monitor the amount of vinculin that fractionated out of solution
along with F-actin as a function of the total concentration of
vinculin, thereby determining the fraction of full-length vinculin
bound to LOV-ipaA. The assay was repeated at several concen-
trations of LOV-ipaA to create a binding curve and calculate
apparent binding affinities (Figures 5B and 5C). In general, theLtd All rights reserved
Figure 5. Binding of LOV-ipaA to Full-Length Vinculin Is Measured through an Actin Cosedimentation Assay
(A) Full-length vinculin, LOV-ipaA, and polymerized actin are incubated 1 hr at room temperature. Vinculin that is bound to LOV-ipaA will bind polymerized actin.
The mixture is centrifuged at 150,000 g, pelleting polymerized actin and all vinculin bound to it out of solution.
(B andC) SDS-PAGEgel of LOV-ipaA C450A and (C) LOV-ipaA I532E A536E actin cosedimentation assaywith vinculin. Molar ratios from 1:0 to 1:50 vinculin:LOV-
ipaA were used. Supernatant (S) and pellet (P) fractions are shown side by side. Apparent binding affinity curves of fraction of vinculin bound to actin versus
concentration of LOV-ipaA are plotted below. Error bars represent standard error of the mean.
See also Table S2.
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vinculin than those observed for binding to the isolated D1
domain, because in the full-length protein there is competition
with the autoinhibited state of vinculin (Le Clainche et al.,
2010). For instance, peptides from the protein talin bind to the
vinculin D1 domain with an affinity of 15 nMbut bind to full-length
vinculin with an affinity of 5 mM (Izard and Vonrhein, 2004; Le
Clainche et al., 2010). LOV-ipaA with the lit-state mutant bound
with an apparent affinity of 8 mM to vinculin, whereas the dark-
state mimetics bound with an affinity of 56 mM (Table S2). The
binding of vinculin to ipaA in the presence of polymerized actin
also gives us a window into the reactions that occur in vivo,
where full-length vinculin must be bound both by talin and by
F-actin in order to engage in integrin signaling. The difference
in binding affinity between lit and dark states of LOV-ipaA to
full-length vinculin in the presence of polymerized actin suggests
that LOV-ipaA may be a relevant photoswitch for probing such
signaling in vivo.
Photo-Activatable Yeast Transcription
To demonstrate that the caged peptides can be used to colocal-
ize proteins and activate signaling events in living cells, we usedChemistry & Biology 19,the LOV-ipaA-vinculin D1 interaction as a heterodimerization
switch for controlling gene expression. The experiments were
performed in Saccharomyces cerevisiae, as it is an orthogonal
system, lacking proteins that would cross-react with the LOV-
ipaA-vinculin D1 interaction. We linked LOV-ipaA L623A to the
GAL4 activation domain (AD), while linking vinculin D1 (vinD1)
to the GAL4 binding domain (BD), and monitored the GAL4-
induced activation of the transcriptional GAL promoter through
a yeast two-hybrid assay. This is a strategy that has been widely
used to identify protein-protein interactions. In our case, LOV-
ipaA and vinculin D1 should only interact upon irradiation with
blue light, thus bringing the GAL4 AD and BD into proximity (Fig-
ure 6A). The full GAL4 protein can then activate the expression of
reporter genes downstream of theGAL promoter. We tested the
ability to activate the reporter gene LacZ under both dark- and
lit-state conditions through quantification of b-galactosidase
activity (Figure 6B). We observed an activity of 5 Miller units
under blue light conditions, 20 Miller units with the LOV-ipaA
L623A lit-state mimetic, and 30 units using the ipaA peptide.
Almost no activity (0.4 Miller units) was seen under dark or
dark-state conditions, and no activity was seen in empty vector
negative controls. We also tested activation of genes MEL1,507–517, April 20, 2012 ª2012 Elsevier Ltd All rights reserved 513
Figure 6. LOV-ipaA Is Used as a Light-Inducible Heterodimerization Tool
(A) LOV-ipaA L623A is linked to the GAL4 activation domain (AD), whereas vinculin D1 (vinD1) is linked to GAL4 binding domain (BD). Irradiation with blue light
brings AD-LOV-ipaA into proximity to BD-vinD1, allowing for GAL-induced expression of reporter genes LacZ, MEL1, HIS2, and ADE2.
(B) LacZ expression is quantified. b-galactosidase activity of S. cerevisiae-mated strains containing BD and AD linked proteins, as specified, is shown. Error bars
represent standard error of the mean.
(C)S. cerevisiae-mated strains containing BD-vinD1 and AD-LOV-ipaAmutants, as indicated, are grown in dark or blue light conditions on SD plates. Difference in
levels of transcription of MEL1, HIS3, and ADE2 in dark- versus lit-state conditions is seen.
See also Figure S4.
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plating BD-vindD1 colonies mated with AD-LOV-ipaA L623A
lit- and dark-state mimetic mutants or AD-LOV-ipaA L623A WT
(Figure 6C). We saw strong growth of colonies containing LOV-
ipaA L623A lit mimetic orWT grown in blue light on plates lacking
His, as well as those lacking His and Ade, indicating expression
of both HIS3 and ADE2 genes. Furthermore, colonies were blue,
indicating expression of the MEL1 gene, whose product,
a-galactosidase, interacted with the x-a-gal substrate for blue
screening. Colonies containing LOV-ipaA L623A dark mimetic
or WT grown in the dark grew on control plates but did not
grow on plates lacking His or Ade, showing low to no expression
of HIS2, ADE2, or MEL1 genes. This indicates that LOV-ipaA-
vinculin D1 heterodimerization can be used as a tool to photo-
control yeast gene expression.
The LOV-ipaA L623Amutation was critical to achieving a lit- to
dark-state change of phenotype in yeast gene expression. When
experiments for MEL1 and HIS3 were conducted using LOV-514 Chemistry & Biology 19, 507–517, April 20, 2012 ª2012 ElsevieripaA lacking this mutation, no observable growth change was
seen between colonies containing lit- and dark-state AD-LOV-
ipaA mated with BD-vinD1 (Figure S4). The binding affinity of
LOV-ipaA to vinculin D1 was hence so tight, even in the dark
state, as to allow binding events and subsequent yeast gene
expression to occur. The L623A mutation shifted the binding
affinity of LOV-ipaA for vinculin D1 to a range in which there
was no binding in the dark but significant activation in the light.
This result highlights the usefulness of being able to tune the
switches for specific applications.
DISCUSSION
We have shown that protein-binding peptides can be embedded
in the AsLOV2-Ja helix so that their affinity for effector proteins is
weakened in the dark but is enhanced when light-activation
releases the Ja helix from the LOV domain. The approach is
applicable to a variety of peptide sequences because onlyLtd All rights reserved
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maintain favorable interactions with LOV domain. Additionally,
most protein-binding peptides contain residues that can be
mutated without significantly weakening affinity for binding
partners. In the case of LOV-ipaA and LOV-SsrAC, we also
took advantage of the fact that not all of the peptide needs to
be embedded in the Ja helix to create a steric block against
effector binding. In this scenario, only a few residues from the
N-terminal portion of the peptide need to be compatible with
the folded Ja helix.
For some applications, it may be necessary to tune the
designed photoswitch to have a dark-state activity and dynamic
range compatible with the desired outcome. In the yeast two-
hybrid experiments with LOV-IpaA, we found that we needed
to weaken dark-state binding in order to prevent gene expres-
sion in the dark. We accomplished this by introducing amutation
that weakens the baseline affinity of IpaA for vinculin. Whereas
the initial design switched from 3.5 nM to 69 nM affinity for vin-
culin, the mutant switched from 2.4 mM to >40 mM. The switching
power of the LOV-peptide switches were also manipulated by
introducing mutations that stabilize the interaction between the
Ja helix and the rest of the LOV domain, as well as by varying
how deeply the caged peptide was embedded in the helix. It
was somewhat surprising that the SsrA peptide had significantly
lower litstate affinity for SspB when embedded in the N-terminal
portion of the Ja helix than when placed at the C terminus. NMR
experiments with the WT AsLOV2 domain indicate that the helix
undocks as a cooperative unit when the protein is activated with
light (Yao et al., 2008). This suggests that there should be similar
levels of access to residues in the N- and C-terminal regions of
the Ja helix in the lit state; therefore, we expected that lit-state
binding affinity for the peptide would be relatively insensitive to
where the peptide was placed in the Ja helix. Our results indicate
that the N-terminal portion of the Ja helix may be less accessible
in the lit state, perhaps by transient interactions with the hydro-
phobic face of the LOV domain b sheet. Additionally or alterna-
tively, the mutations we have made to the Ja helix to create
LOV-SsrAN may have resulted in stronger interactions between
the Ja helix and the rest of the AsLOV2 domain in the light.
Both the LOV-ipaA- vinculin D1 and the LOV-SsrA-SspB
photo-activatable binding interactions can be harnessed as
tools for photo-activatable heterodimerization. The LOV-ipaA-
vinculin switch can be used in bacteria and in yeast cells, as
these systems do not contain vinculin or vinculin binders that
would affect the LOV-ipaA-vinculin interaction. On the other
hand, the LOV-SsrA-SspB photo-activatable heterodimerization
binders should be useful in higher organisms, such as mamma-
lian cells. LOV-ipaA has a very slow off rate for vinculin D1, so it is
better suited for long timescale applications, such as yeast
mating. In contrast, LOV-SsrA binding to SspB is rapidly revers-
ible so can be used formore transient interactions, such as single
cell motility experiments. In these ways, both LOV-ipaA and
LOV-SsrA should be useful tools to spatially and temporally bring
together proteins for activating signaling cascades.
SIGNIFICANCE
Peptides regulate a variety of biological processes by acting
as competitive inhibitors, allosteric regulators, and localiza-Chemistry & Biology 19,tion signals. Photocontrol of peptide activity is a powerful
tool for precise spatial and temporal control of cellular func-
tion. Our work in this paper focuses on designing and char-
acterizing peptides caged by embedding their sequences
into the Ja helix of the AsLOV2 domain. The peptides ipaA
and SsrA were both effectively caged in this manner, allow-
ing for enhanced peptide-effector binding in the light. Muta-
tions introduced into the AsLOV2 domain increased the
difference between lit- and dark-state effector binding,
whereas the position in which the caged sequence is em-
bedded in the Ja helix and the intrinsic affinity of the peptide
for its target tunes the range of affinities of the photo-
activatable peptide. We discuss ways in which other pep-
tides may be caged in a similar manner using the AsLOV2
domain. We also apply LOV-ipaA as a tool for photo-activat-
able gene expression in Saccharomyces cerevisiae and
describe potential uses for LOV-SsrA.
EXPERIMENTAL PROCEDURES
Cloning
The LOV-ipaA gene was synthesized with a six histidine N-terminal tag
(Genscript, Piscataway, NJ, USA) and cloned into the pET21b vector. The
genes for LOV-SsrA and monomeric SspB were synthesized (Genscript) and
cloned into pQE-80L and pTriEX4 vectors, respectively. All mutations were
performed using site-directed mutagenesis. The vinculin D1 subdomain (resi-
dues 1–258) and full-length vinculin (residues 1–1066) were cloned into a
pET15b vector. See Supplemental Experimental Procedures for protein
expression and purification.
Peptides
Peptides containing the sequence TANNIIKAAKDATTSLSKVLKNIN, TANNII
KAAKDATTSASKVLNIN, TANNIIKAAKDATTSLSKALKNIN, QIEEAANDENY,
LIKKAANDINYAAK, and HVRDAANDEAYMLIK were synthesized at UNC-
Chapel Hill and amine labeled using 5-(and-6)-Carboxytetramethylrhodamine
(TAMRA) dye (Anaspec, Fremont, CA, USA). Peptide concentration was deter-
mined by measuring absorbance of the TAMRA dye at 555 nm using 65,000
M1 cm1 extinction coefficient.
Fluorescence Polarization Experiments
All fluorescence polarization experiments were conducted using a Jobin Yvon
Horiba FluoroMax3 fluorescence spectrometer. TAMRA-labeled peptides
were excited with polarized light at 555 nm, and the polarization of emitted light
was measured at 583 nm. See Supplemental Experimental Procedures for
detailed methods.
Surface Plasmon Resonance
Surface plasmon resonance experiments were conducted using a Biacore
2000 machine (GE Healthcare, Waukesha, WI, USA). Vinculin D1 was immobi-
lized through amine coupling to the surface of a CM5 chip (GE Healthcare).
Different concentrations of LOV-ipaAmutants were flown over the immobilized
protein, and the change in response units over time was recorded. Data were
fit simultaneously for kon and koff to a pseudo-first-order binding model.
Actin Cosedimentation Assays
Purified rabbit actin (Invitrogen) was polymerized for 30 min at room tempera-
ture in 10 mM Tris-HCl (pH 7.5) containing 100 mM KCl, 2 mM MgCl2, 2 mM
DTT, and 1 mM ATP. Vinculin (2 mM) and either ipaA peptide or LOV-ipaA
mutants were mixed for vinculin:ipaA rations of 1:0, 1:1, 1:2.5, 1:5, 1:10,
1:20, or 1:50 per sample. Polymerized actin (12 mM) was added to each
sample, within a volume of 45 ml per sample. Samples were incubated at
room temperature for 1 hr. They were then centrifuged in a TLA-100 rotor
in a Beckman Coulter Optimax XP ultracentrifuge at an acceleration of
150,000 g for 30 min cooled to 20C. Samples were split into supernatant
and pellet fractions. Pellets were resuspended into 45 ml 2x tris-glycine SDS507–517, April 20, 2012 ª2012 Elsevier Ltd All rights reserved 515
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amide gel. Gels were Coomassie stained and analyzed using ImageJ software
to determine the fraction of vinculin present in the pellet versus total vinculin in
each sample (Le Clainche et al., 2010).
Yeast Two-Hybrid Assays
LOV-ipaA L623A WT, lit-state mutants, dark-state mutants, and ipaA were
cloned into a pGADT7 vector and transformed into S. cerevisiae Y187 strain,
whereas the vinculin D1 subdomain was cloned into a pGBKT7 vector and
transformed into S. cerevisiae Y2Hgold strain (Clontech, Mountain View, CA,
USA). Empty vectors were also transformed into the appropriate strains.
Transformed colonies of Y2Hgold and Y187 were mated at 30C overnight
and plated on synthetic dextrose (SD) –Leu –Trp media. For yeast two-hybrid
experiments, mated colonies were serially diluted (1:5, from right to left on
plates shown) and replica plated onto SD –Leu –Trp media; SD –Leu –Trp
mediawith auerobasidin A and 5-bromo-4-chloro-3-indolyl-a-D-gactopyrano-
side (x-a-gal); SD –Leu –Trp –His media with auerobasidin A and x-a-gal; and
SD –Leu –Trp –His –Ade media with auerobasidin A and x-a-gal. Plates were
grown for three days at 30C. For Miller assays, mated colonies were picked
and grown to saturation in SD –Leu –Trp media. Saturated colonies were
diluted to low-log phase and grown for 4 hr under dark or blue light conditions.
Cells were lysed open and treated with chlorophenol red-b-D-galactopyrano-
side (CPRG; Roche) substrate to determine b-galactosidase activity in Miller
units (Kennedy et al., 2010).
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures, two tables, and Supplemental
Experimental Procedures and can be found with this article online at
doi:10.1016/j.chembiol.2012.02.006.
ACKNOWLEDGMENTS
We thank A. Tripathy and the Macromoleular Interaction core facility at UNC-
Chapel Hill for help in biophysical experiments, C. A. Purbeck for help and
advice in conducting yeast 2-hybrid experiments, and M. Rougie for help
with vinculin studies. This work was supported by grants from the National
Institutes of Health (GM093208 and GM057464) and the American Heart
Association (09PRE2100055 to O.I.L.).
Received: November 10, 2011
Revised: January 12, 2012
Accepted: February 1, 2012
Published: April 19, 2012
REFERENCES
Alsallaq, R., and Zhou, H.-X. (2008). Electrostatic rate enhancement and tran-
sient complex of protein-protein association. Proteins 71, 320–335.
Carisey, A., and Ballestrem, C. (2011). Vinculin, an adapter protein in control of
cell adhesion signalling. Eur. J. Cell Biol. 90, 157–163.
Cohen, D.M., Kutscher, B., Chen, H., Murphy, D.B., and Craig, S.W. (2006). A
conformational switch in vinculin drives formation and dynamics of a talin-vin-
culin complex at focal adhesions. J. Biol. Chem. 281, 16006–16015.
Conti, E., Uy, M., Leighton, L., Blobel, G., and Kuriyan, J. (1998).
Crystallographic analysis of the recognition of a nuclear localization signal
by the nuclear import factor karyopherin a. Cell 94, 193–204.
Cooper, S., Khatib, F., Treuille, A., Barbero, J., Lee, J., Beenen, M., Leaver-
Fay, A., Baker, D., Popovic, Z., and Players, F. (2010). Predicting protein struc-
tures with a multiplayer online game. Nature 466, 756–760.
Crosson, S., and Moffat, K. (2001). Structure of a flavin-binding plant photore-
ceptor domain: insights into light-mediated signal transduction. Proc. Natl.
Acad. Sci. USA 98, 2995–3000.
Crosson, S., and Moffat, K. (2002). Photoexcited structure of a plant photore-
ceptor domain reveals a light-driven molecular switch. Plant Cell 14, 1067–
1075.516 Chemistry & Biology 19, 507–517, April 20, 2012 ª2012 ElsevierDas, R., and Baker, D. (2008). Macromolecular modeling with rosetta. Annu.
Rev. Biochem. 77, 363–382.
Fan, H.Y., Morgan, S.-A., Brechun, K.E., Chen, Y.-Y., Jaikaran, A.S.I., and
Woolley, G.A. (2011). Improving a designed photocontrolled DNA-binding
protein. Biochemistry 50, 1226–1237.
Gautier, A., Nguyen, D.P., Lusic, H., An, W., Deiters, A., and Chin, J.W. (2010).
Genetically encoded photocontrol of protein localization in mammalian cells.
J. Am. Chem. Soc. 132, 4086–4088.
Halavaty, A.S., and Moffat, K. (2007). N- and C-terminal flanking regions
modulate light-induced signal transduction in the LOV2 domain of the blue
light sensor phototropin 1 from Avena sativa. Biochemistry 46, 14001–14009.
Harper, S.M., Neil, L.C., and Gardner, K.H. (2003). Structural basis of a photo-
tropin light switch. Science 301, 1541–1544.
Harper, S.M., Christie, J.M., and Gardner, K.H. (2004a). Disruption of the LOV-
Jalpha helix interaction activates phototropin kinase activity. Biochemistry 43,
16184–16192.
Harper, S.M., Neil, L.C., Day, I.J., Hore, P.J., and Gardner, K.H. (2004b).
Conformational changes in a photosensory LOV domain monitored by time-
resolved NMR spectroscopy. J. Am. Chem. Soc. 126, 3390–3391.
Huala, E., Oeller, P.W., Liscum, E., Han, I.S., Larsen, E., and Briggs, W.R.
(1997). Arabidopsis NPH1: a protein kinase with a putative redox-sensing
domain. Science 278, 2120–2123.
Izard, T., and Vonrhein, C. (2004). Structural basis for amplifying vinculin acti-
vation by talin. J. Biol. Chem. 279, 27667–27678.
Izard, T., Tran Van Nhieu, G., and Bois, P.R. (2006). Shigella applies molecular
mimicry to subvert vinculin and invade host cells. J. Cell Biol. 175, 465–475.
Kennedy, M.J., Hughes, R.M., Peteya, L.A., Schwartz, J.W., Ehlers, M.D., and
Tucker, C.L. (2010). Rapid blue-light-mediated induction of protein interac-
tions in living cells. Nat. Methods 7, 973–975.
Kleiger, G., Saha, A., Lewis, S., Kuhlman, B., and Deshaies, R.J. (2009). Rapid
E2-E3 assembly and disassembly enable processive ubiquitylation of cullin-
RING ubiquitin ligase substrates. Cell 139, 957–968.
Le Clainche, C., Dwivedi, S.P., Didry, D., and Carlier, M.-F. (2010). Vinculin is
a dually regulated actin filament barbed end-capping and side-binding protein.
J. Biol. Chem. 285, 23420–23432.
Lee, J., Natarajan, M., Nashine, V.C., Socolich, M., Vo, T., Russ, W.P.,
Benkovic, S.J., and Ranganathan, R. (2008). Surface sites for engineering allo-
steric control in proteins. Science 322, 438–442.
Levchenko, I., Grant, R.A., Wah, D.A., Sauer, R.T., and Baker, T.A. (2003).
Structure of a delivery protein for an AAA+ protease in complex with a peptide
degradation tag. Mol. Cell 12, 365–372.
Levskaya, A., Weiner, O.D., Lim, W.A., and Voigt, C.A. (2009). Spatiotemporal
control of cell signalling using a light-switchable protein interaction. Nature
461, 997–1001.
Lockless, S.W., and Ranganathan, R. (1999). Evolutionarily conserved path-
ways of energetic connectivity in protein families. Science 286, 295–299.
Mo¨glich, A., and Moffat, K. (2010). Engineered photoreceptors as novel opto-
genetic tools. Photochem. Photobiol. Sci. 9, 1286–1300.
Nguyen, A., Rothman, D.M., Stehn, J., Imperiali, B., and Yaffe, M.B. (2004).
Caged phosphopeptides reveal a temporal role for 14-3-3 in G1 arrest and
S-phase checkpoint function. Nat. Biotechnol. 22, 993–1000.
Nhieu, G.T., and Izard, T. (2007). Vinculin binding in its closed conformation by
a helix addition mechanism. EMBO J. 26, 4588–4596.
Nikolovska-Coleska, Z., Wang, R., Fang, X., Pan, H., Tomita, Y., Li, P., Roller,
P.P., Krajewski, K., Saito, N.G., Stuckey, J.A., and Wang, S. (2004).
Development and optimization of a binding assay for the XIAP BIR3 domain
using fluorescence polarization. Anal. Biochem. 332, 261–273.
Salomon, M., Christie, J.M., Knieb, E., Lempert, U., and Briggs, W.R. (2000).
Photochemical and mutational analysis of the FMN-binding domains of the
plant blue light receptor, phototropin. Biochemistry 39, 9401–9410.
Saunders, R.M., Holt, M.R., Jennings, L., Sutton, D.H., Barsukov, I.L., Bobkov,
A., Liddington, R.C., Adamson, E.A., Dunn, G.A., and Critchley, D.R. (2006).Ltd All rights reserved
Chemistry & Biology
Designing Phototswitchable PeptidesRole of vinculin in regulating focal adhesion turnover. Eur. J. Cell Biol. 85,
487–500.
Singh, N., Jabeen, T., Sharma, S., Roy, I., Gupta, M.N., Bilgrami, S.,
Somvanshi, R.K., Dey, S., Perbandt, M., Betzel, C., et al. (2005). Detection
of native peptides as potent inhibitors of enzymes. Crystal structure of the
complex formed between treated bovine alpha-chymotrypsin and an autocat-
alytically produced fragment, IIe-Val-Asn-Gly-Glu-Glu-Ala-Val-Pro-Gly-Ser-
Trp-Pro-Trp, at 2.2 angstroms resolution. FEBS J. 272, 562–572.
Strickland, D., Moffat, K., and Sosnick, T.R. (2008). Light-activated DNA
binding in a designed allosteric protein. Proc. Natl. Acad. Sci. USA 105,
10709–10714.
Strickland, D., Yao, X., Gawlak, G., Rosen, M.K., Gardner, K.H., and Sosnick,
T.R. (2010). Rationally improving LOV domain-based photoswitches. Nat.
Methods 7, 623–626.
Swartz, T.E., Corchnoy, S.B., Christie, J.M., Lewis, J.W., Szundi, I., Briggs,
W.R., and Bogomolni, R.A. (2001). The photocycle of a flavin-binding domain
of the blue light photoreceptor phototropin. J. Biol. Chem. 276, 36493–36500.
Swartz, T.E., Wenzel, P.J., Corchnoy, S.B., Briggs, W.R., and Bogomolni, R.A.
(2002). Vibration spectroscopy reveals light-induced chromophore and protein
structural changes in the LOV2 domain of the plant blue-light receptor photo-
tropin 1. Biochemistry 41, 7183–7189.Chemistry & Biology 19,Thompson, G., Owen, D., Chalk, P.A., and Lowe, P.N. (1998). Delineation of
the Cdc42/Rac-binding domain of p21-activated kinase. Biochemistry 37,
7885–7891.
Tran Van Nhieu, G., Ben-Ze’ev, A., and Sansonetti, P.J. (1997). Modulation of
bacterial entry into epithelial cells by association between vinculin and the
Shigella IpaA invasin. EMBO J. 16, 2717–2729.
Wu, Y.I., Frey, D., Lungu, O.I., Jaehrig, A., Schlichting, I., Kuhlman, B., and
Hahn, K.M. (2009). A genetically encoded photoactivatable Rac controls the
motility of living cells. Nature 461, 104–108.
Yao, X., Rosen, M.K., and Gardner, K.H. (2008). Estimation of the available free
energy in a LOV2-J alpha photoswitch. Nat. Chem. Biol. 4, 491–497.
Yazawa, M., Sadaghiani, A.M., Hsueh, B., and Dolmetsch, R.E. (2009).
Induction of protein-protein interactions in live cells using light. Nat.
Biotechnol. 27, 941–945.
Young, D.D., and Deiters, A. (2007). Photochemical control of biological
processes. Org. Biomol. Chem. 5, 999–1005.
Zoltowski, B.D., Vaccaro, B., and Crane, B.R. (2009). Mechanism-based
tuning of a LOV domain photoreceptor. Nat. Chem. Biol. 5, 827–834.507–517, April 20, 2012 ª2012 Elsevier Ltd All rights reserved 517
